Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Pfizer Podcasts

show episodes
 
Science Will Win is a podcast that takes listeners under the microscope on some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating scie ...
  continue reading
 
Women's Health is your destination for compelling, stand-out series that touch on all aspects of women's health. While each series may focus on a different topic, they're united in their commitment to candid conversations that destigmatize women's health issues and highlight real life people. This podcast feed is powered by Pfizer.
  continue reading
 
Artwork
 
Listen to FREE podcast versions of Rebel News livestreams and premium shows, The Ezra Levant Show and The Gunn Show with Sheila Gunn Reid. Like what you hear? Consider becoming a RebelNews+ subscriber at http://RebelNewsPlus.com for access to video versions, premium shows, feature documentaries and exclusive content.
  continue reading
 
Artwork

1
FT News Briefing

Financial Times

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Daily
 
A rundown of the most important global business stories you need to know for the coming day, from the newsroom of the Financial Times. Available every weekday morning. Hosted on Acast. See acast.com/privacy for more information.
  continue reading
 
Artwork

1
B's in a Pod

Pfizer Hemophilia

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
A podcast series sponsored by Pfizer Hemophilia where host Becky VanSant (whose daughter has hemophilia B) speaks with patients, caregivers, and friends in the hemophilia community to talk about a range of important issues.
  continue reading
 
Artwork

1
Stock Movers

iHeartPodcasts

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Daily+
 
Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.
  continue reading
 
Get the lowdown on high finance each week with Barron’s columnist Jack Hough. Business leaders and trendspotters, insights and absurdities—this is Wall Street like you've never heard before.
  continue reading
 
Artwork
 
The Antigen podcast goes behind the science of vaccines. We examine basic science principles, review vaccine history, explore the many facets of their global impact (including COVID-19), and the public sentiment about vaccines around the world. In our latest season, we will dive into maternal immunization: the history, the challenges, the innovations, and the exciting developments to come. This podcast is created by Pfizer.
  continue reading
 
Artwork

1
AMA Update

American Medical Association

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters. Find all AMA podcasts at ama-assn.org/podcasts.
  continue reading
 
Artwork

4
Heads Talk ®

Elaine Pringle Schwitter

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
A Fly on the Boardroom Wall Weekly, in-depth dialogues with industry titans and top executives. From FTSE and S&P CEOs to C-suite leaders of renowned institutions, ℍ𝕖𝕒𝕕𝕤 𝕋𝕒𝕝𝕜® offers "𝔸 𝔽𝕝𝕪 𝕆𝕟 𝕋𝕙𝕖 𝔹𝕠𝕒𝕣𝕕𝕣𝕠𝕠𝕞 𝕎𝕒𝕝𝕝" insights into the pressing topics shaping today's business, finance, and technology landscape. The Heads of the world's biggest corporations discuss current and future industry matters with ℍ𝕖𝕒𝕕𝕤 𝕋𝕒𝕝𝕜®, providing a unique perspective on the pulse of global commerce. 𝕎𝕖 𝕝𝕚𝕜𝕖 𝕥𝕠 𝕤𝕥𝕒𝕣𝕥 ...
  continue reading
 
Artwork

1
Inflammation Nation

Arthritis Ireland

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Inflammation Nation is a podcast from Arthritis Ireland aimed at increasing awareness and understanding of arthritis and related conditions. www.arthritisireland.ie Inflammation Nation is supported by Pfizer.
  continue reading
 
Retired Career Australian Infantryman, Sniper Team Leader, Visual Tracker, Tri Service Wilderness Survival Instructor, Retired Private Investigator. Now homesteading with Texan wife and 4 kids in the Appalachians in Kentucky. genghismfkhan.substack.com
  continue reading
 
Artwork

1
WSJ Minute Briefing

The Wall Street Journal

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Daily+
 
The top business headlines from The Wall Street Journal, three times daily. Whether it’s the latest on overseas markets, economic news out of Washington or closing numbers from Wall Street, you'll be in the know in a flash.
  continue reading
 
Artwork
 
Brew Markets breaks down the day’s most compelling stock market stories and explores what they mean for you. Hosted by Ann Berry, an investor, board member and former CEO, the show delivers refreshing insights into trading trends and money moves, every weekday afternoon.
  continue reading
 
Artwork
 
Know Plan Go is an eight-part podcast series by Gulf News focusing on protecting yourself from viral respiratory infections. Developed in partnership with Pfizer and hosted by Lachlan Kitchen, this series serves as a vital resource to enhance public awareness and understanding of the connection between viral respiratory infections and pre-existing chronic conditions.
  continue reading
 
CNBC’s “Squawk on the Street” with Carl Quintanilla, Jim Cramer and David Faber is broadcast from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential Chief Executive Officers and greatest market minds.
  continue reading
 
Stay blessed in the battle! Show guests include: L.A. Marzulli, Gary Wayne, KrisAnne Hall, Patrick Wood, Kate Dalley, Dr. Laura Sanger, Carrie Madej, Scott Mitchell, Mark Carpenter, Timothy Alberino, Professor Robin McCutcheon, David DuByne, Marjory Wildcraft, Joel Salatin, JC Hall, Dr. Sean Brooks, Vicki Joy Anderson, The Kilted Prepper, storytellers, researchers and more.
  continue reading
 
A weekly roundup of the most significant event-driven and special situations news, with notable guests every month! Brought to you by your hosts Asif Suria and Tamanna Suria, The Special Situations Report is a podcast powered by Inside Arbitrage.
  continue reading
 
Focused on reducing the morbidity, mortality, and burden associated with venous thromboembolism (VTE), experts in this series describe the clinical presentation of VTE, its proper management (including special populations, such as those with cancer), and appropriate dosing of current treatment options. Listen and learn as clinicians relate practical applications of evidence-based guidelines for initial and extended VTE treatment, and secondary prevention. This activity is supported by an edu ...
  continue reading
 
Artwork

4
Finding Freedom

John Odermatt

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
We are born free and we will die free..... the time in between, can be complicated. Freedom is constantly under attack, either by governments and institutions, or our own egos. Sometimes when we build our own prison walls around us, escaping can be incredibly difficult. On Finding Freedom we deliver interviews with real people, sharing real stories of overcoming the odds, persevering injustice and unlocking their potential. This show has been created to inspire you. Life is hard. And Finding ...
  continue reading
 
Artwork
 
Inside 340B Report is your exclusive, behind-the-scenes window into the latest news and developments in the 340B drug pricing program, straight from the journalists at 340B Report. Each episode, published twice a month, brings listeners inside 340B Report's newsroom for a candid, insider's perspective on the evolving drug pricing policy landscape from the journalists who cover it daily.
  continue reading
 
Artwork

1
Pharmaceutical Executive

Pharmaceutical Executive Podcast

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
  continue reading
 
Artwork
 
The Dr. Bob Martin Show is the largest weekend syndicated health talk show on radio today. The program includes callers’ questions and comments, breaking health news, and special features such as The Health Alternative and Outrage and Mystery of the Week. Listeners will learn about nutrition, diet, exercise, vitamins, herbal supplements, homeopathy, healthy lifestyle, mind-body medicine, and many other healing techniques.
  continue reading
 
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm. Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
  continue reading
 
Is there any hope at all of building and maintaining a free society? If so, how? If you are among "the remnant", this might be the show for you. See blog & discussion at: https://bretigne.substack.com/
  continue reading
 
Artwork

601
Viewpoints Radio

Marty Peterson, Gary Price, Evan Rook, Ebony McMorris | AURN

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Daily
 
Sit down with Viewpoints each week as we report on social issues, the environment, history, food – you name it. What’s it like to give birth in prison? Could the plague resurface with climate change? How has politics been permanently reshaped by the Trump era? Candid stories on topics you should know, plus Culture Crash – a three-minute recap on a timely topic in media to keep you up-to-date on all things music, TV and film. Hosted by Marty Peterson, Gary Price, Ebony McMorris, Evan Rook and ...
  continue reading
 
Artwork

1
I Love Negotiating

Jan Potgieter

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
www.ilovenegotiating.com. Jan Potgieter is an internationally acclaimed business negotiation expert. With 16 years of elite level negotiation experience gained on assignment in more than 50 countries working with some of the world’s best known brands including Pfizer, adidas, BP, Vodafone, Nokia, TFL, the NHS and others, Jan has mastered what it takes to produce elite level negotiation results. However, negotiation isn't exclusively reserved for the marketplace. You negotiate every day, with ...
  continue reading
 
Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com, Contract Pharma Direct eNewsletters, and social media channels.
  continue reading
 
Medical Affairs and Communications need to catch-up. The field is being left in the dust by the cutting edge methods and practices in other industries. We’re going to change that. On Transforming Medical Communications we talk to the biggest and brightest names in medical affairs to find out what they’re doing to push our industry forwards and build for the future. If you’re looking for actionable insights into cutting edge developments in the world of medical communications, hit subscribe a ...
  continue reading
 
Artwork

1
Equity ASA

The Australian Shareholder's Association

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
This podcast is a production of Finpods Pty Ltd and Phil Muscatello. Phil is the host of the Shares for Beginners podcast. You can find out more about Phil and listen to Shares for Beginners at https://www.sharesforbeginners.com/ Many successful investors credit their success to ongoing learning and education, but if you’re riding the share market solo, where do you start? Equity ASA is brought to you by the Australian Shareholders’ Association to help you stay informed and to build financia ...
  continue reading
 
Artwork
 
Natural health tips by Review Swami will make your life easy.Use natural herbs, spices,fruits and everyday item to manage diabetes, blood pressure, obesity, digestive issue and heart health.
  continue reading
 
Artwork

1
ShockWaveNews

Eric Erb

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Welcome to Shock Wave News We Cover Alternative and International News, Opinion, Commentary, And Information From Around the World. #independent #news #politics #opinion #commentary
  continue reading
 
Loading …
show series
 
In today’s Pharmaceutical Executive Daily, we cover Pfizer’s lawsuits against Metsera and Novo Nordisk over alleged intellectual property infringement, Eli Lilly’s $3 billion investment in a new Netherlands manufacturing site, and the latest wave of biotech partnerships and licensing agreements driving innovation.…
  continue reading
 
Plus: First Brands’ new management accuses founder Patrick James of fraud. And Stellantis’s Chrysler recalls over 300,000 hybrid Jeeps over battery fire risks. Zoe Kuhlkin hosts. Sign up for WSJ’s free What’s News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street …
  continue reading
 
The tech sector under pressure: Carl Quintanilla, Jim Cramer and David Faber began the show with Palantir shares down sharply despite better-than-expected Q3 results and upbeat revenue guidance. Hear what CEO Alex Karp told CNBC about short sellers as Palantir shares remain among this year's best performers on the S&P 500. Pfizer and Novo Nordisk s…
  continue reading
 
On this episode of Stock Movers: - Palantir Technologies (PLTR) shares fall as much as 6.1% in premarket trading on Tuesday, taking a breather after rallying more than 170% this year. The data-analysis software company raised its full-year forecast and reported third-quarter results that beat expectations. While analysts are broadly positive on the…
  continue reading
 
Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing for wider global dollar adoption. Mentioned in this podcast: Palantir li…
  continue reading
 
Episode 56: Today, Ann breaks down Kimberly-Clark’s purchase of Tylenol maker Kenvue - with the drug in the political spotlight, who stands to win and what is there to lose? Then we look at Amazon’s cloud hosting wins while the company struggles to deliver on Whole Food’s grocery business. Finally, Ann breaks down Pfizer and Novo Nordisk’s unpreced…
  continue reading
 
Summary: In this episode of the Special Situations Report, hosts Asif and Tamanna Suria discuss the latest developments in the event-driven investing world, focusing on M&A activity, stock buybacks, insider trading, spinoffs, and significant management changes. The two continue with the new format by focusing on four key stories, including a potent…
  continue reading
 
Send us a text No guest tonight which means we have a bunch of housekeeping to catch up on. We will chat about the current happenings of the day, playing some relevant sound bites and taking your calls later in the show. Call in 248-238-8155. SUPPORT THE SHOW Buy Me A Coffee http://buymeacoffee.com/Dangerousinfopodcast SubscribeStar http://bit.ly/4…
  continue reading
 
The Rebel News podcasts features free audio-only versions of select RebelNews+ content and other Rebel News long-form videos, livestreams, and interviews. Monday to Friday enjoy the audio version of Ezra Levant's daily TV-style show, The Ezra Levant Show, where Ezra gives you his contrarian and conservative take on free speech, politics, and foreig…
  continue reading
 
On this episode of Stock Movers: - Arista Networks (ANET) shares fell more than 11% in postmarket trading after the company’s forecast for adjusted gross margin in the fourth quarter fell short of the average analyst estimate. - Axon (AXON) drops 20% postmarket after the Taser maker reported disappointing third-quarter adjusted EPS and agreed to bu…
  continue reading
 
The pullback sent Wall Street’s “fear index” up over 10 percent. Plus: Tesla stock falls after Norway rejects Elon Musk’s pay package. Katherine Sullivan hosts. Sign up for the WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal report…
  continue reading
 
Episode 57: Today, Ann examines why famed hedge fund investor, Michael Burry is betting against Palantir & NVIDIA and which CEO called him crazy for shorting chips. Then we look for nuggets in quarterly earnings: Hertz is back in the driver’s seat, while Yum! Is open to selling Pizza Hut. Later, FiServ’s stock dropped off a cliff - did the CEO prom…
  continue reading
 
On this episode of Stock Movers: - Palantir Technologies (PLTR) shares fall, taking a breather after rallying more than 170% this year. The data-analysis software company raised its full-year forecast and reported third-quarter results that beat expectations. While analysts are broadly positive on the report, they flag concerns over the stock’s pre…
  continue reading
 
Matt Walsh, host of "The Matt Walsh Show" on The Daily Wire, to talk about the implications of Zohran Mamdani becoming NYC mayor, the rise of the progressive Muslim socialist, the shocking layout of the ballot that seems to favor Mamdani, why so many Americans support unfettered immigration from third-world countries, what could happen in Minneapol…
  continue reading
 
The EMJ GOLD podcast returns with a special mini series, hosted by Isabel O'Brien, and a fresh format designed with busy listeners in mind. Each of the five episodes will be released in shorter, bite-sized parts, making it easier than ever to dive into the topics that matter most to healthcare professionals and industry leaders alike. To launch the…
  continue reading
 
America is witnessing a silent crisis — a stunning surge in cognitive decline over the last decade that’s leaving scientists scrambling for answers. From memory loss and brain fog to full-blown dementia at younger ages, the numbers are skyrocketing. And the question no one in the mainstream wants to ask: what changed? In this episode, Grant exposes…
  continue reading
 
Stocks pulled back in early trading but came off the lows during the hour, as Palantir fell and volatility rose. Goldman Sachs Chief US Equity Strategist David Kostin joins with a red flag for the market that he’s seeing from earnings season. Seema Mody gives an update on Wall Street’s reaction to Palantir’s quarter, and harsh comments from CEO Ale…
  continue reading
 
Cramer tells investors when this stock gets hit you want to have room to buy. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswiz…
  continue reading
 
On this episode of Stock Movers: - Palantir Technologies (PLTR) shares fall, taking a breather after rallying more than 170% this year. The data-analysis software company raised its full-year forecast and reported third-quarter results that beat expectations. While analysts are broadly positive on the report, they flag concerns over the stock’s pre…
  continue reading
 
On this episode of Stock Movers: - Palantir Technologies (PLTR) shares fall, taking a breather after rallying more than 170% this year. The data-analysis software company raised its full-year forecast and reported third-quarter results that beat expectations. While analysts are broadly positive on the report, they flag concerns over the stock’s pre…
  continue reading
 
On this episode of Stock Movers: - Palantir Technologies (PLTR) shares fall as much as 6.1% in premarket trading on Tuesday, taking a breather after rallying more than 170% this year. The data-analysis software company raised its full-year forecast and reported third-quarter results that beat expectations. While analysts are broadly positive on the…
  continue reading
 
With social media and digital platforms dominating the conversation, email marketing might seem like yesterday's news. However, for Medical Affairs professionals seeking to engage HCPs, email remains one of the most significant yet underutilized channels in their communication strategies. In this episode of Transforming Medical Communications, Wesl…
  continue reading
 
On today's podcast: 1) Zohran Mamdani’s lead heading into the New York City mayoral election has withstood a furious push from Republicans, establishment Democrats and a coalition of Wall Street dealmakers. Aspects of Mamdani’s campaign that some thought would doom his candidacy — his vociferous criticism of Israel’s actions in Gaza, his past calls…
  continue reading
 
Election Day in New York City arrives with socialist frontrunner Zohran Mamdani leading the polls, as a prominent activist supporter publicly warns she’ll “hold him accountable” if he fails to deliver on his left-wing promises once in office. A new Democracy Matters report finds six in ten working-class voters view Democrats as “woke, weak, and out…
  continue reading
 
On this episode of Stock Movers: - Associated British Foods said it is conducting a review that could lead to a separation of the Primark clothing retailer from the rest of its business. - Telefonica shares fell the most in more than five years after Spain’s largest telecom operator by revenue announced it will slash 2026 dividend by half. - Royal …
  continue reading
 
The next frontier of medicine is focused on highly targeted drug therapies that could expand the possibilities of individualized patient care. Today, scientists are working on a particular type of molecule that could harness multiple capabilities and treat inflammatory and autoimmune diseases in ways never done before. In this episode, co-hosts Dr.…
  continue reading
 
Send us a text Tonight we welcome Amber Harris, the managing director of Michigan Bitcoin Trade Council and she is here to teach us about the ins and outs of Bitcoin and cryptos. The Michigan Bitcoin Trade Council (MiBTC), based in Lansing, is a trailblazing membership organization dedicated to championing Michigan’s vibrant Bitcoin community. Our …
  continue reading
 
On this episode of Stock Movers: - Palantir (PLTR) raised its annual revenue outlook to $4.4 billion and outpaced analyst estimates for third-quarter sales, citing “accelerating and otherworldly” growth for its artificial intelligence and data analytics products. Palantir shares gained as much as 7% in after-hours trading following the report, befo…
  continue reading
 
The Rebel News podcasts features free audio-only versions of select RebelNews+ content and other Rebel News long-form videos, livestreams, and interviews. Monday to Friday enjoy the audio version of Ezra Levant's daily TV-style show, The Ezra Levant Show, where Ezra gives you his contrarian and conservative take on free speech, politics, and foreig…
  continue reading
 
Amazon closes at a record high following an OpenAI deal. Plus: Kimberly-Clark agrees to buy Tylenol maker Kenvue. Katherine Sullivan hosts. Sign up for the WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and …
  continue reading
 
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Tim Stenovec and Carol Massar. On this episode of Stock Movers: - Amazon (AMZN) was up 4% at the close. Analysts raised price targets after Amazon reported earnings last week. A…
  continue reading
 
Megyn Kelly is joined by Walter Kirn, editor-at-large of "County Highway," to discuss Trump’s return to 60 Minutes with a lengthy and news-making sit-down, Norah O'Donnell's biased questions, Trump's answer about increasing ICE raids, Trump’s comments about “communist” Zohran Mamdani, his jabs at CBS News and comments about Bari Weiss in an unrelea…
  continue reading
 
On this episode of Stock Movers: - Cisco Systems (CSCO) is rising after the company unveiled a new all-in-one product called Unified Edge to help retail stores, health care facilities and factories use artificial intelligence with a single rack of equipment. - Walt Disney Co. (DIS) is declining after it asked YouTube TV to restore the broadcast of …
  continue reading
 
Jimmy Dore and Reportage author James Corbett discuss a recent conversation on CNBC where the panel discussed the problem of wealth inequality in the United States, and suggest that a civil war between the haves and the have nots may be looming. Corbett argues that the ruling oligarchs deliberately promote cultural and partisan conflicts to prevent…
  continue reading
 
The Stinchfield Podcast exposes the staggering waste, fraud, and abuse inside America’s SNAP food stamp program. Billions of taxpayer dollars are being drained each year as illegal aliens and ineligible recipients take advantage of a system meant to feed the truly needy. Meanwhile, the data shows an uncomfortable truth — SNAP recipients are, on ave…
  continue reading
 
Cramer lays out why this Wall Street darling may be undervalued. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for inf…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play